GE Healthcare provides a range of healthcare technologies and services aimed at improving patient care. Its main products include imaging systems, mobile diagnostic devices, patient monitoring solutions, and advanced software for data analysis. These products help medical professionals make informed decisions and enhance the efficiency of healthcare delivery. Unlike many competitors, GE Healthcare invests significantly in research and development, allocating $1 billion each year to innovate and enhance its offerings. The company's goal is to support healthcare providers in delivering better patient outcomes, as evidenced by its technology supporting over 300,000 patients daily and managing 2 billion patient scans each year.

Bill & Melinda Gates Foundation

Vestor Capital

Data & Analytics

Healthcare

GE Healthcare

Laza Medical, a Los Gatos, CA-based Shifamed portfolio company advancing AI-powered robotically-assisted imaging solution for cardiovascular interventions, raised $36M in Series A funding

Laza Medical Raises $36M in Series A funding

/PRNewswire/ -- MediView XR, Inc., a leading clinical augmented reality med-tech company, announced today that it has secured $15M in strategic funding from...

MediView XR, Inc. Secures $15M Strategic Funding Round with Backing from Leading Collaborators across Clinical, Industry and Government

AliveCor, a Mountain View, CA-based provider of FDA-cleared personal electrocardiogram (ECG) technology solutions, raised an undisclosed amount in Series F funding. The round was led by GE Healthcare, with participation from NGK-NTK (through a CVC partnership with Pegasus Tech Ventures) and existing investors including Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, and WP Global Partners

Alivecor Closes Series F Financing

GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, announced that it has signed an agreement to acquire Caption Health, Inc., a

GE HealthCare to Acquire Caption Health, Expanding Ultrasound to Support New Users Through FDA-Cleared, AI-Powered Image Guidance

CHALFONT ST GILES, England & NORTH BILLERICA, Mass.--(BUSINESS WIRE)--GE Healthcare and Lantheus Holdings Inc (NASDAQ: LNTH) have announced that the recent Phase III clinical trial of their investigational radiotracer, [18F]flurpiridaz, has met its co-primary endpoints of exceeding a 60 percent threshold for both sensitivity and specificity for detecting Coronary Artery Disease (CAD). The findings, shared at the American Society of Nuclear Cardiology (ASNC) Congress, in Florida, U.S., also demonstrate [18F]flurpiridaz Positron Emission Tomography (PET) has higher diagnostic efficacy and image quality in patients with suspected CAD, compared with Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI), the predominant procedure used in nuclear cardiology today. SPECT MPI represents approximately 6 million procedures per year in the U.Si. The Phase III Open-Label Study, which involved over 600 patients across sites in the U.S., Europe and Canada assessed the diagnostic efficacy of [18F]flurpiridaz in detecting CAD, the most common form of heart diseaseii and the leading cause of death globallyiii, with invasive coronary angiography as a standard of truth. More than 120 million people are affected by CAD globally each yeariv and in the U.S. alone, approximately 20 million adults have CAD, with nearly 383,000 deaths recorded in 2020v

Ge Healthcare And Lantheus Phase Iii Clinical Trial Finds [18F]Flurpiridaz Pet Radiotracer Could Improve Detection Of Coronary Artery Disease

CHICAGO --(BUSINESS WIRE)--Feb. 16, 2024-- GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 13,000,000 shares of its common stock (the “GEHC Shares”)

GE HealthCare Technologies Inc. Prices Secondary Offering of 13,000,000 Shares | GE HealthCare

Vestor Capital LLC purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 658 shares of the company’s stock, valued at approximately $53,000. Other hedge funds have also modified their holdings […]

Vestor Capital LLC Makes New Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

GE HealthCare (Nasdaq: GEHC) today announced it received a grant from the Bill & Melinda Gates Foundation for more than $44 million to create user

GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries

MediView XR, a Cleveland, OH-based clinical augmented reality med-tech company, raised $15M in strategic funding.The round saw participation from Mayo Clinic, Cleveland Clinic, GE HealthCare, JobsOhio Capital Growth Fund, Inside View Investments, LLC, and KKVS Syndicate.The company intends to use the funds to enable the scale up of its augmented reality surgical navigation, medical imaging and remote collaboration platform.Led by Mina S. Fahim, President and CEO, MediView is a  med-tech company working to advance human health through its digital augmented reality ecosystem. Its augmented reality visualization platform works to deliver 3D data to transform image-guided medical procedures with 3D X-ray vision visualization, remote collaboration, and evidence-based data insights. Currently, MediView is delivering these technologies through partnerships with organizations GE Healthcare and Microsoft.FinSMEs16/05/2023

Mediview Xr Raises $15M In Strategic Funding Round

CHICAGO--(BUSINESS WIRE)--GE Healthcare announced US FDA 510(k) clearance of its breakthrough AIR Recon DL for 3D and PROPELLER imaging sequences1. The benefits of AIR Recon DL are extended by these new features to nearly all Magnetic Resonance Imaging (MRI) clinical procedures, covering all anatomies and enabling better image quality, shorter scan times, and enhanced patient experience. Already, GE Healthcare’s AIR Recon DL deep learning-based image reconstruction technology for MRI has fundamentally shifted the balance between image quality and scan time. Now, with the solution’s expanded compatibility from 2D to 3D imaging sequences, physicians can quickly and confidently diagnose patients with improved signal-to-noise ratio (SNR) and sharpness. 3D imaging provides for more clinical efficiency, allowing radiologists to eliminate the need for multiple 2D acquisitions - potentially leading to faster diagnosis

Ge Healthcare’S Air Recon Dl Receives Fda Clearance Of 3D  Motion-Insensitive Imaging Applications For Next-Level Image Quality And Patient Experience In Mri

Siete nuevas empresas de tecnología de la salud han sido seleccionadas oficialmente para formar parte de la segunda remesa de Edison Accelerator en Europa, Oriente Medio y África (EMEA). Edison Accelerator es un programa de aceleración de puesta en marcha y expansión de la atención médica y un punto de encuentro de colaboración entre proveedores de atención médica diseñado por GE Healthcare en asociación con la organización de innovación Wayra UK, el hub que conecta a Telefónica y sus socios corporativos con empresas tecnológicas disruptivas en todo el mundo. Durante los próximos seis meses, estas siete nuevas empresas obtendrán acceso a las soluciones e integraciones de GE Healthcare, así como a los proveedores de atención médica para probar las innovaciones de sus productos en los flujos de trabajo y tecnologías existentes. Esto ayudará a desarrollar, integrar y comercializar soluciones digitales, impulsando el futuro digital de la atención médica

Ge Healthcare Y Wayra Colaboran Con Siete Nuevas Empresas De Tecnología De La Salud Para Impulsar La Transformación Digital De La Atención Médica En Europa, Oriente Medio Y África (Emea)

Supporting teams to bring innovation to healthcare

Alumni

Toronto, Canada, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Six digital health start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program designed by GE Healthcare and delivered in collaboration with Nex Cubed to accelerate, validate, and scale innovative solutions that address important challenges in the healthcare sector. The selected companies all focus on applying Artificial Intelligence (AI) to augment medical imaging with the potential to transform how healthcare is delivered. AI is poised to increase productivity and the efficiency of care delivery and allow healthcare systems to provide better care to more people. AI can help improve the experience of healthcare practitioners, with the goal of enabling them to spend more time in direct patient care and reducing burnout

Ge Healthcare In Collaboration With Nex Cubed Select Six

CHICAGO --(BUSINESS WIRE)--Nov. 7, 2024-- GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 13,281,302 shares of its common stock (the “GEHC Shares”).

GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares | GE HealthCare

GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offeri

GE HealthCare Technologies Inc. Commences Secondary Offering of 10,000,000 Shares

GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire IMACTIS, an innovator in the rapidly growing field of compute

GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance

Nucleus RadioPharma, a Rochester, MN-based integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, raised an undisclosed amount in a Series A extension funding

Nucleus RadioPharma Raises Series A Extension Funding

Those who laud the potential benefits of AI in healthcare are too often silent on the risk of exacerbating the healthcare system's current failings

AI in healthcare - will it help or just make things worse?

Healthcare technology and data analytics provider

GE Healthcare

Healthcare technology and data analytics provider

GE Healthcare

Healthcare technology and data analytics provider

About

Simplify's Take

What believers are saying

What critics are saying

What makes GE Healthcare unique

Recently Posted Jobs

There are no jobs for GE Healthcare right now.